Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic

This systematic review examines current randomized clinical trials of therapeutic agents to treat coronavirus disease 2019 (COVID-19).

Detalles Bibliográficos
Autores principales: Kouzy, Ramez, Abi Jaoude, Joseph, Garcia Garcia, Carolina J., El Alam, Molly B., Taniguchi, Cullen M., Ludmir, Ethan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358910/
https://www.ncbi.nlm.nih.gov/pubmed/32658285
http://dx.doi.org/10.1001/jamanetworkopen.2020.15100
Descripción
Sumario:This systematic review examines current randomized clinical trials of therapeutic agents to treat coronavirus disease 2019 (COVID-19).

Ejemplares similares